RxDoctor Payments Data

Sarah Huber, MD

Obstetrics & Gynecology · Watkinsville, GANPI 1225329899

Payments from drug & device makers

$4,168in general payments, 2019–2025

Across 47 payments — averaging $88.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Axonics, Inc.$155
  • Revance Therapeutics, Inc.$151
  • Applied Medical Resources Corporation$78
  • Aspira Women's Health Inc$60
  • Intuitive Surgical$58
  • plus $117 from 4 others
$630in research payments, 2019–2025

Across 1 payment — averaging $630.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$630

What the payments were for

  • Travel & lodging$2,30155%
  • Food & beverage$1,86745%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,168 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Medicare billing

Part B allowed, 2024
$4,452
Medicare patients
11
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron70$70,192
Mirabegron ErMirabegron28$14,479
Estradiol268$12,732
Darifenacin ErDarifenacin Hydrobromide169$6,554
YuvafemEstradiol71$5,447
Methenamine Hippurate74$4,659
Trospium Chloride91$2,833
Fosfomycin Tromethamine13$2,360
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet30$745
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst87$715
Solifenacin Succinate43$616
Cephalexin65$591
Ibuprofen56$428
NitrofurantoinNitrofurantoin Macrocrystal20$311
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$303

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$51$70,19270 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.

Other obstetrics & gynecology in Watkinsville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →